Hot Features
プレミアム
BioXcel Therapeutics Inc (BTAI)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 35.00 | 0.00 | Derivative Exercise and Retained Stock | - | 26.84k | 0.13% |
| 2026-06-15 | Mr. Richard I. SteinhartSenior VP & CFO | 35.00 | 0.00 | Derivative Exercise and Retained Stock | - | 26.34k | 0.13% |
| 2026-06-15 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 219.00 | 0.00 | Derivative Exercise and Retained Stock | - | 69.94k | 0.31% |
| 2026-06-15 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 35.00 | 0.00 | Derivative Exercise and Retained Stock | - | 26.21k | 0.13% |
| 2026-05-04 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 10.66k | 0.00 | Derivative Exercise and Retained Stock | - | 26.18k | 68.65% |
| 2026-05-04 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | -6.85k | 7.43k | Derivative Exercise and Sale | 1.09 | 26.18k | - |
| 2026-05-04 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 10.94k | 0.00 | Derivative Exercise and Retained Stock | - | 26.80k | 68.97% |
| 2026-05-04 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | -6.56k | 7.11k | Derivative Exercise and Sale | 1.08 | 26.80k | - |
| 2026-05-04 | Mr. Richard I. SteinhartSenior VP & CFO | 10.66k | 0.00 | Derivative Exercise and Retained Stock | - | 26.30k | 68.10% |
| 2026-05-04 | Mr. Richard I. SteinhartSenior VP & CFO | -6.85k | 7.43k | Derivative Exercise and Sale | 1.09 | 26.30k | - |
| 2026-05-04 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | -19.42k | 21.11k | Derivative Exercise and Sale | 1.09 | 69.72k | - |
| 2026-05-04 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 30.34k | 0.00 | Derivative Exercise and Retained Stock | - | 69.72k | 77.03% |
| 2026-05-01 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 18.00k | 0.00 | Derivative Exercise and Retained Stock | - | 39.38k | 84.18% |
| 2026-05-01 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 9.00k | 0.00 | Derivative Exercise and Retained Stock | - | 15.52k | 138.04% |
| 2026-05-01 | Mr. Richard I. SteinhartSenior VP & CFO | 9.00k | 0.00 | Derivative Exercise and Retained Stock | - | 15.65k | 135.44% |
| 2026-05-01 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 9.00k | 0.00 | Derivative Exercise and Retained Stock | - | 15.86k | 131.14% |
| 2026-03-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 383.00 | 0.00 | Derivative Exercise and Retained Stock | - | 21.38k | 1.82% |
| 2026-03-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.65k | 1.03% |
| 2026-03-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.86k | 1.00% |
| 2026-03-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.52k | 1.05% |
| 2025-12-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 383.00 | 0.00 | Derivative Exercise and Retained Stock | - | 21.00k | 1.86% |
| 2025-12-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.80k | 1.01% |
| 2025-12-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.58k | 1.04% |
| 2025-12-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.45k | 1.07% |
| 2025-10-31 | Mr. David J. MackIndependent Director | 1.69k | 0.00 | Derivative Exercise and Retained Stock | - | 20.32k | 9.10% |
| 2025-09-30 | Mr. David J. MackIndependent Director | 1.69k | 0.00 | Derivative Exercise and Retained Stock | - | 18.62k | 10.01% |
| 2025-09-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 382.00 | 0.00 | Derivative Exercise and Retained Stock | - | 20.62k | 1.89% |
| 2025-09-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.51k | 1.06% |
| 2025-09-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.73k | 1.02% |
| 2025-09-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.38k | 1.08% |
| 2025-08-31 | Mr. David J. MackIndependent Director | 1.69k | 0.00 | Derivative Exercise and Retained Stock | - | 16.93k | 11.11% |
| 2025-07-31 | Mr. David J. MackIndependent Director | 1.69k | 0.00 | Derivative Exercise and Retained Stock | - | 15.24k | 12.50% |
| 2025-07-22 | Mr. Richard I. SteinhartSenior VP & CFO | 625.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.44k | 10.75% |
| 2025-07-22 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 625.00 | 0.00 | Derivative Exercise and Retained Stock | - | 6.66k | 10.36% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
